Guidance on the use of coronary artery stents

Public Health, College of Medicine, University of Wales, Cardiff Dr David Winfield Consultant Haematologist, Royal Hallamshire Hospital, Sheffield NICE Project Team Each appraisal of a technology is assigned to a health technology analyst and a project manager. Dr Alastair Fischer Technical Lead Kathleen Dalby Project Manager 9 Sources of evidence considered by the Committee The following documentation and opinions were made available to the Committee: The Assessment Report for this appraisal was prepared by Liverpool Reviews and Implementation Group, University of Liverpool. • Coronary artery stents: rapid systematic review and economic evaluation, February 2003 • Assessment report – addendum A – data no longer confidential, June 2003 • Assessment report – addendum B - further analysis requested by the Appraisal Committee, May 2003 The following organisations accepted the invitation to participate in this appraisal. They were invited to make submissions and comment on the draft scope, Assessment Report and the Appraisal Consultation Document (ACD). Consultee organisations are provided with the opportunity to appeal against the Final Appraisal Determination. Companies or sponsors: • Abbott Vascular Devices Ltd • Bard Ltd • Biotronik UK Ltd • Boston Scientific Ltd • Cordis • Guidant Ltd • Jomed UK Ltd • Kimal • Medtronic
